Prof. Matt Inada-Kim

Prof. Matt Inada-Kim

Consultant acute medicine, national clinical director infection, antimicrobial resistance and deterioration

Matt is an Acute physician at Hampshire Hospitals, visiting professor at the University of Southampton and Clinical Director for Digital Innovation at Wessex AHSN.
His roles NHS England are as National Clinical Director for Infection management/Sepsis, AMR and Deterioration; for COVID oximetry@home/virtual wards and Lead for the Deterioration and Sepsis CQUINs.
He developed/led on national COVID clinical pathways in all settings/policy/evidence in all settings, disseminating the home monitoring strategy across 18 countries during the pandemic. In Singapore, this led to the government purchasing oximeters for every household.
He is a recognised international expert in sepsis, deterioration, integrated and virtual care and developed multiple webinars with the World Health Organisation, Royal College of Physicians, Royal College of Paediatrics and Child Health, Royal College of Emergency Medicine, British Society for Antimicrobial Chemotherapy and British Geriatric Society. He has given invited lectures and discussions across the world on healthcare policy, systems thinking, healthcare innovations and quality improvement strategies in India, Australia, Tanzania, Zambia, Brazil, Japan, Singapore, Taiwan, Vietnam, Thailand, Indonesia, Malaysia, Philippines, Singapore, Brunei, Lao PDR, Myanmar, Cambodia, Canada, USA and Sri Lanka.

He sits on the RCP Independent advisory group and has helped standardise the country to using NEWS2.
He was clinical lead in Deterioration and Sepsis across Wessex AHSN, leading the regional network 2014-2019; during which Wessex spearheaded NEWS2 implementation, reworking of the national sepsis definition and a human factors based training approach (using simulation) to its management (that led to a regional 13% reduction in mortality), developed ReSTORE2, a common deterioration tool (across community, care homes, ambulances, Eds and hospitals), pathway and documentation.
He has clinically led the development of a unified national dashboard to measure the infection burden (admission, deaths, length of stay, intensive care, treatments, resistance) that he is expanding to all causes- for the use of all national, regional and local healthcare providers and researchers.

He is currently developing integrated infection assessment hubs and virtual wards linked to both diagnostics and therapeutics to optimally manage infections in out of hospital settings.

HSJ award winner in Sepsis 2019, Deterioration 2020 and Patient safety 2021